Answers are grounded in this paper and cite their sources.
Inequities in HIV acquisition and pre-exposure prophylaxis (PrEP) uptake persist in the United States. We present an innovative program that leverages telehealth to increase PrEP access through a unique public health and academic partnership. The Philadelphia TelePrEP Program (PTP) provides free, comprehensive, and accessible PrEP. Patients access the program through a public health sexual wellness website; patients are evaluated via telehealth, labs are completed using at-home testing kits or in-person at a local lab, and both oral and injectable PrEP modalities are prescribed through the program. Uninsured patients are covered through various patient assistance programs. We used patient data from the initial implementation of the PTP from October 2022 to December 2024 to describe the PrEP continuum to assess program reach and engagement by demographic groups. Of 576 unique individuals who scheduled appointments through the PTP website, 474 (82%) attended telehealth visits, 399 (69%) completed lab testing, and 386 (67%) were prescribed PrEP. Most patients who scheduled an appointment were cisgender men (85%), aged 18–34 (71%), and identified as non-Hispanic White (38%) or non-Hispanic Black (26%). Significant disparities in PrEP uptake emerged by gender (cisgender women: 39% vs. men: 70%), race/ethnicity (Black: 59% vs. White: 75%), and HIV risk group (MSM: 80% vs. heterosexual: 59%). The PTP successfully implemented a telehealth model for PrEP delivery, reaching a diverse cohort of Philadelphians. However, significant challenges to expanding access to telePrEP and PrEP more broadly remain, including lower rates of PrEP prescription for Black and Hispanic/Latine populations as well as cisgender women in the program.
No takes yet. Share an insight, caveat, or question.
Safa et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: